Concepts (356)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking | 104 | 2020 | 864 | 14.890 |
Why?
|
| Tobacco Use Disorder | 74 | 2020 | 246 | 13.930 |
Why?
|
| Adolescent Behavior | 51 | 2020 | 193 | 6.430 |
Why?
|
| Smoking Prevention | 37 | 2018 | 162 | 5.050 |
Why?
|
| Substance Withdrawal Syndrome | 18 | 2016 | 122 | 4.320 |
Why?
|
| Behavior, Addictive | 20 | 2020 | 73 | 3.920 |
Why?
|
| Commerce | 19 | 2020 | 56 | 3.780 |
Why?
|
| Personal Autonomy | 17 | 2015 | 68 | 3.720 |
Why?
|
| Nicotine | 19 | 2017 | 117 | 3.160 |
Why?
|
| Adolescent | 116 | 2020 | 6172 | 3.110 |
Why?
|
| Tobacco Products | 12 | 2020 | 80 | 3.030 |
Why?
|
| Smoking Cessation | 31 | 2020 | 551 | 2.620 |
Why?
|
| Tobacco Industry | 13 | 2014 | 19 | 2.480 |
Why?
|
| Tobacco Smoke Pollution | 6 | 2016 | 57 | 1.820 |
Why?
|
| Minors | 6 | 2020 | 8 | 1.780 |
Why?
|
| Male | 96 | 2020 | 29487 | 1.340 |
Why?
|
| Female | 95 | 2020 | 32495 | 1.260 |
Why?
|
| Humans | 140 | 2020 | 62682 | 1.240 |
Why?
|
| Psychometrics | 17 | 2016 | 377 | 1.180 |
Why?
|
| Child | 42 | 2016 | 4444 | 1.170 |
Why?
|
| Craving | 5 | 2016 | 36 | 0.980 |
Why?
|
| Students | 7 | 2016 | 217 | 0.970 |
Why?
|
| Surveys and Questionnaires | 20 | 2018 | 2648 | 0.960 |
Why?
|
| Nicotinic Agonists | 5 | 2015 | 39 | 0.900 |
Why?
|
| Brain | 9 | 2020 | 1550 | 0.880 |
Why?
|
| State Government | 3 | 2018 | 31 | 0.820 |
Why?
|
| Smokers | 4 | 2020 | 119 | 0.820 |
Why?
|
| Law Enforcement | 4 | 2011 | 25 | 0.810 |
Why?
|
| Health Education | 6 | 2008 | 188 | 0.780 |
Why?
|
| Drug and Narcotic Control | 5 | 2011 | 28 | 0.770 |
Why?
|
| Receptors, Nicotinic | 3 | 2020 | 67 | 0.770 |
Why?
|
| Water Pipe Smoking | 5 | 2020 | 9 | 0.760 |
Why?
|
| Family | 3 | 2016 | 240 | 0.740 |
Why?
|
| United States | 31 | 2020 | 7721 | 0.730 |
Why?
|
| Attitude to Health | 5 | 2011 | 291 | 0.670 |
Why?
|
| Plants, Toxic | 6 | 1999 | 13 | 0.660 |
Why?
|
| Counseling | 6 | 2015 | 360 | 0.640 |
Why?
|
| Child Behavior | 10 | 2010 | 64 | 0.630 |
Why?
|
| Young Adult | 15 | 2020 | 4633 | 0.630 |
Why?
|
| Parents | 6 | 2015 | 381 | 0.620 |
Why?
|
| Substance-Related Disorders | 5 | 2020 | 716 | 0.610 |
Why?
|
| Population Surveillance | 2 | 2018 | 203 | 0.610 |
Why?
|
| Government Programs | 1 | 2018 | 20 | 0.600 |
Why?
|
| Motivation | 7 | 2016 | 283 | 0.600 |
Why?
|
| Massachusetts | 19 | 2015 | 2061 | 0.580 |
Why?
|
| Adult | 34 | 2016 | 16629 | 0.560 |
Why?
|
| Health Promotion | 6 | 2018 | 491 | 0.540 |
Why?
|
| Health Surveys | 8 | 2011 | 312 | 0.540 |
Why?
|
| Psychology, Adolescent | 6 | 2009 | 26 | 0.530 |
Why?
|
| Prevalence | 8 | 2016 | 1345 | 0.510 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2015 | 6 | 0.500 |
Why?
|
| Government Regulation | 3 | 2011 | 40 | 0.490 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2015 | 20 | 0.490 |
Why?
|
| Receptors, Opioid, mu | 1 | 2015 | 15 | 0.490 |
Why?
|
| Tobacco, Smokeless | 3 | 2011 | 9 | 0.480 |
Why?
|
| Marketing of Health Services | 3 | 2001 | 23 | 0.480 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2010 | 120 | 0.470 |
Why?
|
| Reproducibility of Results | 12 | 2015 | 1638 | 0.460 |
Why?
|
| Advisory Committees | 1 | 2015 | 112 | 0.460 |
Why?
|
| International Classification of Diseases | 3 | 2010 | 137 | 0.460 |
Why?
|
| Parietal Lobe | 1 | 2014 | 28 | 0.440 |
Why?
|
| Behavior Therapy | 1 | 2015 | 165 | 0.440 |
Why?
|
| Asthma | 3 | 2016 | 433 | 0.430 |
Why?
|
| Gyrus Cinguli | 1 | 2014 | 57 | 0.430 |
Why?
|
| Longitudinal Studies | 10 | 2020 | 1248 | 0.420 |
Why?
|
| Time Factors | 13 | 2018 | 3742 | 0.420 |
Why?
|
| Cross-Sectional Studies | 9 | 2016 | 2540 | 0.400 |
Why?
|
| Schools | 9 | 2020 | 159 | 0.390 |
Why?
|
| Inhalation Exposure | 1 | 2012 | 55 | 0.380 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2012 | 34 | 0.380 |
Why?
|
| Pediatrics | 3 | 2015 | 250 | 0.370 |
Why?
|
| Habits | 1 | 2011 | 21 | 0.360 |
Why?
|
| Age Factors | 9 | 2014 | 1554 | 0.360 |
Why?
|
| Risk Factors | 14 | 2015 | 5303 | 0.360 |
Why?
|
| Benzazepines | 1 | 2011 | 21 | 0.360 |
Why?
|
| Disease Progression | 2 | 2016 | 1159 | 0.360 |
Why?
|
| Maze Learning | 1 | 2011 | 52 | 0.360 |
Why?
|
| Child Welfare | 3 | 2008 | 52 | 0.360 |
Why?
|
| Drug Tolerance | 2 | 2011 | 33 | 0.360 |
Why?
|
| Impulsive Behavior | 1 | 2011 | 28 | 0.350 |
Why?
|
| Quinoxalines | 1 | 2011 | 37 | 0.350 |
Why?
|
| Mental Recall | 3 | 2014 | 91 | 0.340 |
Why?
|
| Guideline Adherence | 3 | 2009 | 306 | 0.340 |
Why?
|
| Primary Health Care | 1 | 2015 | 685 | 0.320 |
Why?
|
| New Zealand | 4 | 2016 | 43 | 0.320 |
Why?
|
| Psychological Theory | 2 | 2015 | 26 | 0.320 |
Why?
|
| Prospective Studies | 13 | 2016 | 3258 | 0.310 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2009 | 36 | 0.310 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 393 | 0.300 |
Why?
|
| Motor Activity | 1 | 2011 | 343 | 0.290 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2017 | 622 | 0.290 |
Why?
|
| Motion Pictures | 1 | 2007 | 11 | 0.280 |
Why?
|
| Social Control, Formal | 3 | 2001 | 20 | 0.270 |
Why?
|
| Health Behavior | 1 | 2010 | 466 | 0.270 |
Why?
|
| Ganglionic Stimulants | 1 | 2007 | 6 | 0.270 |
Why?
|
| Universities | 1 | 2008 | 157 | 0.270 |
Why?
|
| Personality Inventory | 1 | 2006 | 56 | 0.260 |
Why?
|
| Marketing | 3 | 2014 | 19 | 0.260 |
Why?
|
| Physician's Role | 4 | 2003 | 124 | 0.250 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 128 | 0.250 |
Why?
|
| Tobacco Use Cessation | 2 | 2008 | 29 | 0.240 |
Why?
|
| Middle Aged | 12 | 2016 | 17365 | 0.240 |
Why?
|
| Interpersonal Relations | 1 | 2006 | 151 | 0.240 |
Why?
|
| Odds Ratio | 7 | 2011 | 768 | 0.240 |
Why?
|
| Receptors, Cholinergic | 1 | 2005 | 20 | 0.240 |
Why?
|
| Menthol | 2 | 2017 | 6 | 0.230 |
Why?
|
| Manifest Anxiety Scale | 1 | 2004 | 2 | 0.230 |
Why?
|
| Models, Neurological | 1 | 2005 | 80 | 0.230 |
Why?
|
| Taxes | 3 | 2000 | 6 | 0.230 |
Why?
|
| Peer Group | 3 | 2011 | 104 | 0.230 |
Why?
|
| Self-Assessment | 1 | 2004 | 60 | 0.220 |
Why?
|
| Rats | 5 | 2017 | 1978 | 0.220 |
Why?
|
| Social Class | 2 | 2014 | 133 | 0.220 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 46 | 0.220 |
Why?
|
| Nurse's Role | 2 | 2011 | 120 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2016 | 2150 | 0.220 |
Why?
|
| Cyprus | 2 | 2016 | 2 | 0.220 |
Why?
|
| Income | 2 | 2003 | 169 | 0.210 |
Why?
|
| Severity of Illness Index | 4 | 2013 | 1541 | 0.210 |
Why?
|
| Locomotion | 3 | 2017 | 116 | 0.210 |
Why?
|
| Cues | 3 | 2015 | 76 | 0.210 |
Why?
|
| Adolescent Medicine | 1 | 2003 | 6 | 0.210 |
Why?
|
| Respiratory Tract Infections | 1 | 2004 | 89 | 0.210 |
Why?
|
| Social Environment | 3 | 2015 | 93 | 0.210 |
Why?
|
| Injections, Subcutaneous | 2 | 2015 | 70 | 0.210 |
Why?
|
| Pleasure | 2 | 2014 | 13 | 0.210 |
Why?
|
| Risk Assessment | 6 | 2014 | 2040 | 0.210 |
Why?
|
| Seasons | 1 | 2003 | 133 | 0.200 |
Why?
|
| Arousal | 2 | 2014 | 42 | 0.200 |
Why?
|
| Proportional Hazards Models | 3 | 2010 | 727 | 0.200 |
Why?
|
| Socioeconomic Factors | 3 | 2016 | 775 | 0.200 |
Why?
|
| Drug Administration Schedule | 2 | 2015 | 299 | 0.200 |
Why?
|
| Lebanon | 5 | 2020 | 10 | 0.190 |
Why?
|
| Factor Analysis, Statistical | 3 | 2015 | 98 | 0.190 |
Why?
|
| Causality | 2 | 2016 | 58 | 0.190 |
Why?
|
| Brain Mapping | 3 | 2016 | 232 | 0.180 |
Why?
|
| Anxiety | 1 | 2004 | 421 | 0.180 |
Why?
|
| Cohort Studies | 5 | 2009 | 2540 | 0.180 |
Why?
|
| Facility Regulation and Control | 1 | 2000 | 3 | 0.180 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2000 | 7 | 0.170 |
Why?
|
| Industry | 3 | 1996 | 61 | 0.170 |
Why?
|
| Child, Preschool | 3 | 2016 | 1937 | 0.170 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 2174 | 0.170 |
Why?
|
| Sudden Infant Death | 2 | 2004 | 24 | 0.170 |
Why?
|
| Logistic Models | 5 | 2016 | 1273 | 0.170 |
Why?
|
| Age Distribution | 3 | 2015 | 258 | 0.170 |
Why?
|
| Marijuana Smoking | 1 | 2020 | 18 | 0.170 |
Why?
|
| Marijuana Use | 1 | 2020 | 21 | 0.170 |
Why?
|
| Incidence | 3 | 2009 | 1367 | 0.170 |
Why?
|
| Private Sector | 1 | 1999 | 12 | 0.160 |
Why?
|
| Cluster Analysis | 2 | 2016 | 255 | 0.160 |
Why?
|
| Interviews as Topic | 3 | 2007 | 506 | 0.160 |
Why?
|
| Aged | 7 | 2016 | 14254 | 0.160 |
Why?
|
| Australia | 2 | 2010 | 120 | 0.160 |
Why?
|
| Vaping | 1 | 2020 | 44 | 0.160 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2020 | 72 | 0.150 |
Why?
|
| Retrospective Studies | 5 | 2018 | 6533 | 0.150 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2017 | 158 | 0.150 |
Why?
|
| Health Care Costs | 1 | 2001 | 210 | 0.150 |
Why?
|
| Research Design | 2 | 2015 | 572 | 0.150 |
Why?
|
| Colorado | 1 | 2018 | 21 | 0.150 |
Why?
|
| Infant | 4 | 2012 | 1602 | 0.150 |
Why?
|
| Age of Onset | 2 | 2008 | 175 | 0.140 |
Why?
|
| Quebec | 2 | 2009 | 13 | 0.140 |
Why?
|
| Sex Distribution | 2 | 2008 | 252 | 0.140 |
Why?
|
| Perception | 2 | 2009 | 173 | 0.140 |
Why?
|
| Brain Chemistry | 1 | 2017 | 76 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 422 | 0.140 |
Why?
|
| Neural Pathways | 2 | 2016 | 98 | 0.140 |
Why?
|
| Follow-Up Studies | 5 | 2018 | 2445 | 0.140 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 1139 | 0.130 |
Why?
|
| Public Policy | 2 | 1999 | 41 | 0.130 |
Why?
|
| Visual Cortex | 1 | 2016 | 26 | 0.130 |
Why?
|
| Public Health | 2 | 2003 | 186 | 0.130 |
Why?
|
| Tobacco, Waterpipe | 1 | 2016 | 8 | 0.130 |
Why?
|
| Mississippi | 2 | 2015 | 16 | 0.130 |
Why?
|
| Relaxation | 2 | 2007 | 6 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 933 | 0.130 |
Why?
|
| Legislation as Topic | 3 | 1996 | 12 | 0.130 |
Why?
|
| Animals | 8 | 2017 | 20584 | 0.130 |
Why?
|
| Corpus Striatum | 1 | 2016 | 96 | 0.120 |
Why?
|
| Minisatellite Repeats | 1 | 2015 | 6 | 0.120 |
Why?
|
| Regression Analysis | 2 | 2010 | 497 | 0.120 |
Why?
|
| Alleles | 2 | 2015 | 445 | 0.120 |
Why?
|
| Stress, Psychological | 3 | 2011 | 469 | 0.120 |
Why?
|
| Binge Drinking | 1 | 2016 | 37 | 0.120 |
Why?
|
| Chi-Square Distribution | 2 | 2009 | 415 | 0.120 |
Why?
|
| Gene-Environment Interaction | 1 | 2015 | 49 | 0.120 |
Why?
|
| Genotype | 2 | 2015 | 649 | 0.120 |
Why?
|
| Restaurants | 2 | 2018 | 12 | 0.120 |
Why?
|
| Polymorphism, Genetic | 1 | 2015 | 189 | 0.120 |
Why?
|
| Sex Factors | 3 | 2007 | 973 | 0.120 |
Why?
|
| Legislation, Drug | 1 | 2014 | 17 | 0.120 |
Why?
|
| Alcohol Drinking | 2 | 2016 | 313 | 0.120 |
Why?
|
| Patient Education as Topic | 2 | 2007 | 462 | 0.100 |
Why?
|
| Corpus Callosum | 1 | 2013 | 42 | 0.100 |
Why?
|
| Frontal Lobe | 1 | 2013 | 65 | 0.100 |
Why?
|
| Communication | 2 | 2015 | 569 | 0.100 |
Why?
|
| Netherlands | 1 | 2012 | 24 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 485 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 862 | 0.100 |
Why?
|
| Ethics, Pharmacy | 1 | 1992 | 3 | 0.100 |
Why?
|
| Academies and Institutes | 1 | 1992 | 22 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 667 | 0.100 |
Why?
|
| Cartoons as Topic | 1 | 1991 | 1 | 0.100 |
Why?
|
| Predictive Value of Tests | 2 | 2008 | 1077 | 0.100 |
Why?
|
| Pharmacies | 1 | 1992 | 36 | 0.090 |
Why?
|
| Depression | 3 | 2016 | 883 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2012 | 1341 | 0.090 |
Why?
|
| Prisons | 1 | 2012 | 106 | 0.090 |
Why?
|
| Indians, North American | 1 | 2011 | 29 | 0.090 |
Why?
|
| School Nursing | 1 | 2011 | 26 | 0.090 |
Why?
|
| Reference Values | 2 | 2011 | 335 | 0.090 |
Why?
|
| Florida | 1 | 2011 | 48 | 0.090 |
Why?
|
| Varenicline | 1 | 2011 | 11 | 0.090 |
Why?
|
| Data Collection | 2 | 2005 | 384 | 0.090 |
Why?
|
| United States Food and Drug Administration | 1 | 2011 | 90 | 0.090 |
Why?
|
| Greece | 1 | 2010 | 3 | 0.090 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 156 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2012 | 175 | 0.090 |
Why?
|
| Bias | 2 | 2002 | 112 | 0.090 |
Why?
|
| Exploratory Behavior | 2 | 2008 | 36 | 0.090 |
Why?
|
| Otitis Media | 2 | 2004 | 13 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2011 | 168 | 0.090 |
Why?
|
| United Kingdom | 1 | 2010 | 79 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2011 | 229 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 1995 | 378 | 0.080 |
Why?
|
| Manuals as Topic | 1 | 2009 | 8 | 0.080 |
Why?
|
| Trust | 1 | 2011 | 73 | 0.080 |
Why?
|
| Research | 1 | 2011 | 192 | 0.080 |
Why?
|
| Physicians, Family | 2 | 2003 | 75 | 0.080 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2009 | 8 | 0.080 |
Why?
|
| New South Wales | 1 | 2009 | 3 | 0.080 |
Why?
|
| Linear Models | 2 | 2011 | 409 | 0.080 |
Why?
|
| Imagination | 1 | 2008 | 7 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2011 | 5591 | 0.070 |
Why?
|
| Personality Assessment | 1 | 2008 | 28 | 0.070 |
Why?
|
| Truth Disclosure | 1 | 2008 | 57 | 0.070 |
Why?
|
| Practice Management, Medical | 1 | 2008 | 21 | 0.070 |
Why?
|
| Parent-Child Relations | 1 | 2008 | 59 | 0.070 |
Why?
|
| Internet | 1 | 2011 | 463 | 0.070 |
Why?
|
| Probability | 1 | 2008 | 170 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 212 | 0.070 |
Why?
|
| Cotinine | 1 | 2007 | 19 | 0.070 |
Why?
|
| Life Style | 1 | 2009 | 311 | 0.070 |
Why?
|
| Rats, Inbred WKY | 2 | 2017 | 11 | 0.070 |
Why?
|
| Psychological Tests | 1 | 2007 | 45 | 0.070 |
Why?
|
| Endorphins | 1 | 2007 | 12 | 0.070 |
Why?
|
| Nonprescription Drugs | 1 | 2007 | 17 | 0.070 |
Why?
|
| Disease Susceptibility | 1 | 2007 | 166 | 0.070 |
Why?
|
| Mass Media | 2 | 2006 | 31 | 0.070 |
Why?
|
| Saliva | 1 | 2007 | 103 | 0.070 |
Why?
|
| Intention | 1 | 2007 | 69 | 0.070 |
Why?
|
| Statistics as Topic | 1 | 2007 | 148 | 0.070 |
Why?
|
| Primary Prevention | 1 | 2008 | 136 | 0.070 |
Why?
|
| Needs Assessment | 1 | 2008 | 196 | 0.070 |
Why?
|
| Alcoholism | 1 | 1990 | 319 | 0.070 |
Why?
|
| Narcotics | 1 | 2007 | 58 | 0.070 |
Why?
|
| Serotonin | 1 | 2007 | 60 | 0.070 |
Why?
|
| Risk | 1 | 2007 | 375 | 0.070 |
Why?
|
| Norepinephrine | 1 | 2007 | 103 | 0.060 |
Why?
|
| Glutamic Acid | 1 | 2007 | 98 | 0.060 |
Why?
|
| Dopamine | 1 | 2007 | 105 | 0.060 |
Why?
|
| Consensus | 1 | 2007 | 225 | 0.060 |
Why?
|
| Attitude | 2 | 2003 | 100 | 0.060 |
Why?
|
| Financing, Organized | 1 | 2005 | 16 | 0.060 |
Why?
|
| Sexual Behavior | 1 | 2006 | 193 | 0.060 |
Why?
|
| Accidents, Traffic | 1 | 1986 | 152 | 0.060 |
Why?
|
| Receptors, Muscarinic | 1 | 2005 | 14 | 0.060 |
Why?
|
| Internal-External Control | 1 | 2005 | 33 | 0.060 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2004 | 11 | 0.060 |
Why?
|
| Mixed Function Oxygenases | 1 | 2004 | 19 | 0.060 |
Why?
|
| Hospitalization | 1 | 2012 | 1344 | 0.060 |
Why?
|
| Program Evaluation | 2 | 2011 | 485 | 0.060 |
Why?
|
| Recurrence | 1 | 2006 | 634 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 1070 | 0.050 |
Why?
|
| Homeostasis | 1 | 2007 | 367 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 755 | 0.050 |
Why?
|
| Dizziness | 1 | 2004 | 18 | 0.050 |
Why?
|
| Intelligence | 1 | 2004 | 55 | 0.050 |
Why?
|
| Nursing Methodology Research | 1 | 2003 | 53 | 0.050 |
Why?
|
| Family Characteristics | 1 | 2003 | 44 | 0.050 |
Why?
|
| Texas | 1 | 2003 | 57 | 0.050 |
Why?
|
| Nausea | 1 | 2004 | 112 | 0.050 |
Why?
|
| Personality | 1 | 2003 | 29 | 0.050 |
Why?
|
| Pregnancy | 2 | 2004 | 2318 | 0.050 |
Why?
|
| Physician-Patient Relations | 1 | 2006 | 416 | 0.050 |
Why?
|
| Self Report | 2 | 2016 | 371 | 0.050 |
Why?
|
| Risk-Taking | 1 | 2003 | 162 | 0.050 |
Why?
|
| Interview, Psychological | 1 | 2002 | 74 | 0.050 |
Why?
|
| Politics | 1 | 2002 | 34 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2002 | 78 | 0.050 |
Why?
|
| Educational Status | 1 | 2003 | 273 | 0.050 |
Why?
|
| Models, Econometric | 1 | 2001 | 14 | 0.040 |
Why?
|
| Smoking Water Pipes | 1 | 2020 | 6 | 0.040 |
Why?
|
| Management Audit | 1 | 2000 | 3 | 0.040 |
Why?
|
| Cross-Cultural Comparison | 1 | 2000 | 46 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2001 | 220 | 0.040 |
Why?
|
| Crime | 1 | 2000 | 53 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 2008 | 608 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2001 | 308 | 0.040 |
Why?
|
| Chewing Gum | 2 | 2007 | 9 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 658 | 0.030 |
Why?
|
| Rats, Inbred SHR | 1 | 2016 | 5 | 0.030 |
Why?
|
| Adenoidectomy | 1 | 1996 | 7 | 0.030 |
Why?
|
| Tonsillectomy | 1 | 1996 | 11 | 0.030 |
Why?
|
| Middle Ear Ventilation | 1 | 1996 | 5 | 0.030 |
Why?
|
| Fires | 1 | 1996 | 14 | 0.030 |
Why?
|
| Bronchitis | 1 | 1996 | 27 | 0.030 |
Why?
|
| Self Concept | 1 | 2016 | 111 | 0.030 |
Why?
|
| Germany | 1 | 2016 | 53 | 0.030 |
Why?
|
| Respiratory Tract Diseases | 1 | 1996 | 37 | 0.030 |
Why?
|
| Office Visits | 1 | 1996 | 47 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2016 | 96 | 0.030 |
Why?
|
| Models, Psychological | 1 | 1995 | 97 | 0.030 |
Why?
|
| Fetal Death | 1 | 1995 | 14 | 0.030 |
Why?
|
| Infant Mortality | 1 | 1995 | 20 | 0.030 |
Why?
|
| Abortion, Spontaneous | 1 | 1995 | 31 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 1995 | 59 | 0.030 |
Why?
|
| Health Policy | 1 | 1996 | 187 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 1996 | 219 | 0.030 |
Why?
|
| Cough | 1 | 1996 | 183 | 0.030 |
Why?
|
| Canada | 1 | 2014 | 154 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 1118 | 0.030 |
Why?
|
| Anisotropy | 1 | 2013 | 60 | 0.030 |
Why?
|
| Wounds and Injuries | 1 | 1996 | 238 | 0.030 |
Why?
|
| Pneumonia | 1 | 1996 | 288 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 74 | 0.030 |
Why?
|
| Pattern Recognition, Visual | 1 | 1991 | 40 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2011 | 242 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 1992 | 220 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2011 | 358 | 0.020 |
Why?
|
| Decision Making | 1 | 1992 | 402 | 0.020 |
Why?
|
| Role Playing | 1 | 1988 | 8 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 2008 | 34 | 0.020 |
Why?
|
| Tablets | 1 | 2007 | 16 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2007 | 31 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 1990 | 1110 | 0.020 |
Why?
|
| Ethanol | 1 | 1990 | 321 | 0.020 |
Why?
|
| Oxygen | 1 | 2008 | 316 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2008 | 228 | 0.020 |
Why?
|
| Cytochrome P-450 CYP2A6 | 1 | 2004 | 1 | 0.010 |
Why?
|
| Social Behavior | 1 | 2005 | 91 | 0.010 |
Why?
|
| Self Efficacy | 1 | 2005 | 202 | 0.010 |
Why?
|
| Health Planning Guidelines | 1 | 2003 | 32 | 0.010 |
Why?
|
| Organizational Policy | 1 | 2003 | 48 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2002 | 34 | 0.010 |
Why?
|
| Demography | 1 | 2002 | 172 | 0.010 |
Why?
|
| Family Practice | 1 | 2003 | 213 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2003 | 458 | 0.010 |
Why?
|
| Focus Groups | 1 | 2002 | 299 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 714 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 453 | 0.010 |
Why?
|
| Emotions | 1 | 2002 | 223 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 725 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 5403 | 0.010 |
Why?
|